Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients
V Suresh, Jitendra Lakhani, R Balaraman
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (27)
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. 2020-02-01 · Expand citations
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
- Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. 2015-10-15 · Expand citations
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. 2012-02-07 · Expand citations
- Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
- The pharmacology of psilocybin. 2002-10-01 · Expand citations
- OpenAlex W1966152590
- OpenAlex W2015045196
- OpenAlex W2044384616
- OpenAlex W2065164655
- OpenAlex W2066231855
- OpenAlex W2115111325
- OpenAlex W2121828573
- OpenAlex W2123179625
- OpenAlex W2138201557
- OpenAlex W2141585509
- OpenAlex W2144269887
- OpenAlex W2145998697
- OpenAlex W2157195823
- OpenAlex W2366678371
- OpenAlex W2772914282
- OpenAlex W2793644042
- OpenAlex W2940589604
- OpenAlex W3200199305
- OpenAlex W6701272370
- OpenAlex W885150323
Cited by — these papers cite this paper (0)
No citing papers identified in the available metadata. This does not establish that none exist.